Wendy Yan is a Senior Vice President and has served as Chief Regulatory Officer since 2014. For the previous 18 years, Ms. Yan held senior regulatory affairs positions at GlaxoSmithKline, AstraZeneca, and Bayer. Prior to that, she was a licensed pharmacist at Beijing Drug Control Institute, an organization within the former China Food and Drug Administration.

Ms. Yan received her Bachelor of Medicine from Beijing Traditional Chinese Medicine University and an MBA from Staffordshire University (U.K.).